These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2994847)

  • 1. Monoclonal antibodies raised against Lewy bodies in brains from subjects with Parkinson's disease.
    Hirsch E; Ruberg M; Dardenne M; Portier MM; Javoy-Agid F; Bach JF; Agid Y
    Brain Res; 1985 Oct; 345(2):374-8. PubMed ID: 2994847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of two antigens in parkinsonian Lewy bodies.
    Hirsch E; Ruberg M; Portier MM; Dardenne M; Agid Y
    Brain Res; 1988 Feb; 441(1-2):139-44. PubMed ID: 3359227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewy bodies are immunoreactive with antibodies raised to gelsolin related amyloid-Finnish type.
    Wisniewski T; Haltia M; Ghiso J; Frangione B
    Am J Pathol; 1991 May; 138(5):1077-83. PubMed ID: 1850958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments.
    Forno LS; Sternberger LA; Sternberger NH; Strefling AM; Swanson K; Eng LF
    Neurosci Lett; 1986 Mar; 64(3):253-8. PubMed ID: 2421208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lewy body in Parkinson's disease.
    Forno LS
    Adv Neurol; 1987; 45():35-43. PubMed ID: 3030070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-rich cytoplasmic bodies of substantia nigra and locus ceruleus. A comparative study in parkinsonian and normal brain.
    Issidorides MR; Mytilineou C; Whetsell WO; Yahr MD
    Arch Neurol; 1978 Oct; 35(10):633-7. PubMed ID: 697603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease and dementia with neuronal inclusions in the cerebral cortex: Lewy bodies or Pick bodies.
    Tiller-Borcich JK; Forno LS
    J Neuropathol Exp Neurol; 1988 Sep; 47(5):526-35. PubMed ID: 2845001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
    No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between Lewy bodies and pale bodies in Parkinson's disease.
    Dale GE; Probst A; Luthert P; Martin J; Anderton BH; Leigh PN
    Acta Neuropathol; 1992; 83(5):525-9. PubMed ID: 1320323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.
    Tompkins MM; Basgall EJ; Zamrini E; Hill WD
    Am J Pathol; 1997 Jan; 150(1):119-31. PubMed ID: 9006329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
    Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM
    Brain; 2005 Nov; 128(Pt 11):2665-74. PubMed ID: 16219675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson's disease.
    Pappolla MA; Shank DL; Alzofon J; Dudley AW
    Hum Pathol; 1988 Jan; 19(1):27-31. PubMed ID: 2447008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell death mechanisms in Parkinson's disease.
    Jellinger KA
    J Neural Transm (Vienna); 2000; 107(1):1-29. PubMed ID: 10809400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of cell size and nucleolar size in Lewy body containing neurons of substantia nigra in Parkinson's disease.
    Gertz HJ; Siegers A; Kuchinke J
    Brain Res; 1994 Feb; 637(1-2):339-41. PubMed ID: 8180816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lewy bodies in parkinsonism share components with intraneuronal protein bodies of normal brains.
    Issidorides MR; Mytilineou C; Panayotacopoulou MT; Yahr MD
    J Neural Transm Park Dis Dement Sect; 1991; 3(1):49-61. PubMed ID: 1712207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lewy bodies of Parkinson's disease. Immune electron microscopic demonstration of neurofilament antigens in constituent filaments.
    Pappolla MA
    Arch Pathol Lab Med; 1986 Dec; 110(12):1160-3. PubMed ID: 3022672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
    Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.